Tivozanib Active Not Recruiting Phase 2 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01885949Tivozanib + Enzalutamide in Adv Prostate Cancer